AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

2019 Analytical Report for Healthcare Licensing with Focus on Small Molecules - 140+ Licensing News of Companies Across North America (52%), Europe (32%), and Asia (16%) - ResearchAndMarkets.com

May 9, 2019

DUBLIN--(BUSINESS WIRE)--May 9, 2019--The “Analytical Report for Healthcare Licensing with focus on Small Molecules” report has been added to ResearchAndMarkets.com’s offering.

Small molecules continue to play a significant role in the pharmaceutical industry as many companies develop small molecules for almost every imaginable indication. 140+ licensing news with focus on Small Molecules are reported and analyzed to provide a snapshot view of the current business trends here.

Analytical data coverage:

  • January 1, 2018 to March 31, 2019 licensing deals and negotiations
  • 140+ worldwide Small Molecules focused healthcare licensing news of companies across North America (52%), Europe (32%), Asia (16%)
  • Small-mid-large cap companies covered - LargeCap (26%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered - Pharmaceuticals (38%), Biotech (45%), Healthcare Services (12%), Medical Devices (2%)
  • 14 medicine groups studied - Oncology (36%), Neurology (19%), Allergy & Immunology (10%)
  • 8+ variables analyzed

User benefits:

  • Immediate access to current global licensing trends for Small Molecules
  • Succinct summaries of licensing deals and negotiations held worldwide
  • Quick to-the-point analytical references
  • In-depth updates on wider perspective of Small Molecules
  • Directions to the emerging business prospects

Key analysis in the report:

  • Leading countries in Small Molecules focused licensing
  • Most active healthcare sub-sectors in Small Molecules focused licensing
  • Distribution of Small Molecules focused licensing deals among market cap groups
  • Comparisons of different medicine groups in Small Molecules focused licensing
  • Companies currently engaging the most in Small Molecules focused licensing
  • Dynamics of varied licensing payments arrangements worldwide

Report useful to:

  • Small Molecules focused healthcare companies seeking licensing opportunities
  • Small Molecules focused healthcare companies seeking new market base
  • Executives of healthcare companies negotiating licensing for Small Molecules
  • Investors analyzing varied kinds of transaction options for Small Molecules focused licensing

Key Topics Covered

Introduction

Research Design

Chapter 1: Analysis of healthcare inventions with focus on Small Molecules licensed during the past five quarters

1.1 Number of licensing deals with focus on Small Molecules

1.2 Countries with most licensing deals with focus on Small Molecules

1.3 Healthcare sub-sectors with most licensing deals with focus on Small Molecules

1.4 Market capitalization groups with most licensing deals with focus on Small Molecules

1.5 Medicine groups with most licensing deals with focus on Small Molecules

1.6 Leading companies with most licensing deals with focus on Small Molecules

1.7 Licensing payment arrangements most followed in licensing deals with focus on Small Molecules

Chapter 2: Key licensing deals with focus on Small Molecules during the past five quarters - By type of licensing deal

Chapter 3: Global healthcare inventions with focus on Small Molecules licensed during the past five quarters - By region and company name

Chapter 4: Summary and conclusions

Appendices

Appendix 1 List of companies/institutes covered

a) By region, country and company name

b) By sub-industry, country and company name

c) By market capitalization group, country and company name

d) By medicine group, country and company name

e) By terms of payment, country and company name

Appendix 2 List of non-listed companies covered - By country and company name

Appendix 3 List of not-for-profit institutes covered - By country and institute name

Companies Mentioned

Alphabetical List of Sample 30 Companies/Institutes (of the total 250 companies covered) in the Report:

Company/Institute name - Sub Industry - Country

  • Eisai Co. Ltd. (Pharmaceuticals) (Japan)
  • Elevian, Inc. (Biotech) (United States)
  • Eli Lilly and Company (Pharmaceuticals) (United States)
  • EpiDestiny Inc. (Biotech) (United States)
  • Epigen Biosciences Inc.(Biotech) (United States)
  • Epizyme, Inc. (Biotech) (United States)
  • E-Scape Bio (Biotech) (United States)
  • Evotec AG (Pharmaceuticals) (Germany)
  • ExCellThera Inc. (Pharmaceuticals) (Canada)
  • Exelixis Inc. (Pharmaceuticals) (United States)
  • Expansion Therapeutics (Biotech) (United States)
  • F. Hoffmann-La Roche Ltd (Pharmaceuticals) (Switzerland)
  • Fate Therapeutics, Inc. (Biotech) (United States)
  • Ferring Holding SA (Pharmaceuticals) (Switzerland)
  • Fibrocor Therapeutics LP (Pharmaceuticals) (Canada)
  • FORMA Therapeutics, Inc. (Biotech) (United States)
  • Frequency Therapeutics (Biotech) (United States)
  • Galapagos NV (Biotech) Belgium
  • Genentech, Inc. (Biotech) (United States)
  • Genisphere, LLC (Pharmaceuticals) (United States)
  • Gilead Sciences, Inc. (Biotech) (United States)
  • Gladstone Institutes (Biotech) (United States)
  • GlaxoSmithKline plc (Pharmaceuticals) (United Kingdom)
  • Grunenthal GmbH (Pharmaceuticals)(Germany)
  • GTN Ltd. (Biotech) (United Kingdom)
  • Harvard University (Healthcare Services) (United States)
  • Hebei Medical University Biomedical Engineering Center (Healthcare Services) (China)
  • HitGen Ltd. (Biotech) (China)
  • Hoffmann-La Roche Inc. (Pharmaceuticals) (United States)
  • Hoth Therapeutics, Inc. (Pharmaceuticals) (United States)

For more information about this report visit https://www.researchandmarkets.com/r/u3cwb5

View source version on businesswire.com:https://www.businesswire.com/news/home/20190509005641/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Healthcare Services

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENERAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/09/2019 10:46 AM/DISC: 05/09/2019 10:46 AM

http://www.businesswire.com/news/home/20190509005641/en